Cream for dry, itchy skin from cancer therapy
Part of Cancer, Skin clinical trials.
This study tests a moisturizing cream (with pre- and postbiotics and niacinamide) to see if it reduces dryness and itching in cancer patients who are on a type of targeted therapy called anti-EGFR drugs. If you have dry, itchy skin from your treatment, this cream might help soothe it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be on an anti-EGFR cancer therapy (like cetuximab or panitumumab) for at least 3 months.
- You should not have a moderate to severe acne-like rash on your face or chest from your treatment.
- You must not be using any other moisturizers or steroid creams on the affected skin right now.
- You cannot have had a chronic dry-skin condition (like lichen or ichthyosis) or an itchy problem of unknown cause in the past.
- You must be able to give your informed consent and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a topical cream (HT-001) to treat skin rashes caused by EGFR inhibitors. It aims to see whether the cream is safe and can reduce rash symptoms and discomfort.
This study measures how your skin changes physically and mechanically during breast cancer treatment. It may help doctors better manage side effects like skin dryness or tightness.
This study tests a special cream that may prevent skin irritation (radiation dermatitis) caused by radiation therapy for breast cancer. The cream is made from natural weak acids and aims to protect the skin by keeping the skin's microbiome healthy.
This trial tests a combination of cosmetic products for people with dry, very dry, or itchy skin. The goal is to see if these products help soothe your skin and reduce itching.
This study tests whether a special moisturizing lotion (Cerave Neuroceramide) can help relieve dry, itchy skin in older adults. It’s for people 55+ who have moderate to severe dryness and itching, and who also have eczema, take certain medications, or have a condition like diabetes.
This trial tests a new cream called ATR04-484 to see if it can help with the painful rash that often appears on the face and chest during EGFR inhibitor cancer treatment. The cream is applied to the skin, with the goal of reducing redness, bumps, and discomfort.
Hear when a new Xerosis Cutis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.